These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14977433)

  • 21. Estimating the particle size characteristics of therapeutic aerosols.
    Dolovich M; Smaldone GC
    J Aerosol Med; 1999; 12(4):215-6. PubMed ID: 10724636
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhaler devices in infants and children: challenges and solutions.
    Everard ML
    J Aerosol Med; 2004; 17(2):186-95. PubMed ID: 15294070
    [No Abstract]   [Full Text] [Related]  

  • 23. Dry powder inhalers and the risk of error.
    Terzano C
    Respiration; 2008; 75(1):14-5. PubMed ID: 18185025
    [No Abstract]   [Full Text] [Related]  

  • 24. The current laboratory determination of "respirable mass" is not clinically relevant.
    Newhouse MT
    J Aerosol Med; 1998; 11 Suppl 1():S122-32. PubMed ID: 10180724
    [No Abstract]   [Full Text] [Related]  

  • 25. Aerosol therapy: regimen and device compliance in daily practice.
    Everard ML
    Paediatr Respir Rev; 2006; 7 Suppl 1():S80-2. PubMed ID: 16798605
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug delivery to the respiratory tract and drug dosimetry.
    Atkins P; Clark AR
    J Aerosol Med; 1994; 7(1):33-8. PubMed ID: 10147057
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of excipients on the stability and aerosol performance of nebulized aviscumine.
    Steckel H; Eskandar F; Witthohn K
    J Aerosol Med; 2003; 16(4):417-32. PubMed ID: 14977432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review.
    Mitchell J; Newman S; Chan HK
    AAPS PharmSciTech; 2007 Dec; 8(4):E110. PubMed ID: 18181531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aerosols as a way of treating patients.
    Clarke SW
    Eur J Respir Dis Suppl; 1986; 146():525-33. PubMed ID: 3536557
    [No Abstract]   [Full Text] [Related]  

  • 30. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part I: Design.
    Marple VA; Roberts DL; Romay FJ; Miller NC; Truman KG; Van Oort M; Olsson B; Holroyd MJ; Mitchell JP; Hochrainer D
    J Aerosol Med; 2003; 16(3):283-99. PubMed ID: 14572326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nebulizers: principles and performance.
    Hess DR
    Respir Care; 2000 Jun; 45(6):609-22. PubMed ID: 10894454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The technology of inhalation therapy].
    Freund B
    Rev Mal Respir; 1998 Sep; 15 Suppl 2():S57-8. PubMed ID: 9809347
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparisons between inhaled fine particle fractions and lung dose for nebulized aerosols.
    Finlay WH; Stapleton KW; Zuberbuhler P
    J Aerosol Med; 1998; 11 Suppl 1():S65-72. PubMed ID: 10180735
    [No Abstract]   [Full Text] [Related]  

  • 34. Face masks for aerosols-there is more science..
    Amirav I; Mandelberg A
    Pediatr Pulmonol; 2010 Mar; 45(3):221-3. PubMed ID: 20146372
    [No Abstract]   [Full Text] [Related]  

  • 35. Using a filter bypass leakage test for aerosol sampling cassettes.
    Baron PA
    Appl Occup Environ Hyg; 2002 Sep; 17(9):593-7. PubMed ID: 12216585
    [No Abstract]   [Full Text] [Related]  

  • 36. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):72-80. PubMed ID: 16442248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug delivery devices: issues in drug development.
    Byron PR
    Proc Am Thorac Soc; 2004; 1(4):321-8. PubMed ID: 16113453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nebulizer efficiency: modeling versus in vitro testing.
    Dennis JH
    Respir Care; 2007 Aug; 52(8):984-8. PubMed ID: 17650352
    [No Abstract]   [Full Text] [Related]  

  • 39. Design principles of liquid nebulization devices currently in use.
    Rau JL
    Respir Care; 2002 Nov; 47(11):1257-75; discussion 1275-8. PubMed ID: 12425742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can in vitro particle size measurements be used to predict pulmonary deposition of aerosol from inhalers?
    Thiel CG
    J Aerosol Med; 1998; 11 Suppl 1():S43-52. PubMed ID: 10180732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.